secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cullinan Therapeutics, Inc. (CGEM)
CIK:        0001789972
Form:       8-K
Filed at:   2026-06-16T21:18:15+00:00
Accession:  0001193125-26-272890
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cullinan Therapeutics reports annual meeting results; all proposals approved
----------------------------------------------------------------------------

- Shareholders elected Nadim Ahmed and Stephen Webster as Class III directors for three-year terms.
- Ratified KPMG LLP as independent auditor for fiscal year 2026 with 53.7M votes for, 36.8K against.
- Advisory vote on executive compensation approved with 48.5M for, 1.1M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/0001193125-26-272890-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/cgem-20260616.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-272890

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer